Visual Impairment News and Research

Latest Visual Impairment News and Research

Increasing eye patching is effective at treating persistent amblyopia in children

The standard treatment for amblyopia, a condition of poor vision in an otherwise healthy eye, is patching: covering a child's better-seeing eye with a patch for two hours a day to improve vision in the weaker eye.

24 Sep 2013

Study: People with cataract-related vision loss who undergo cataract surgery live longer

People with cataract-related vision loss who have had cataract surgery to improve their sight are living longer than those with visual impairment who chose not to have the procedure, according to an Australian cohort study published this month in Ophthalmology, the journal of the American Academy of Ophthalmology. After comparing the two groups, the researchers found a 40 percent lower long-term mortality risk in those who had the surgery.

5 Sep 2013

Meta-analysis indicates protective effect of statins in preventing cataracts

Cataracts are the leading cause of visual impairment worldwide affecting more than 20 million people. Statins are among the most commonly prescribed medications. In the USA they are prescribed to 1 in 3 people over 45 years of age at a cost of $35 billion annually.

2 Sep 2013

CP Family releases video showing children with cerebral palsy playing video games using new technology

Cerebral Palsy Family Network has released a video showing children and teens with cerebral palsy delighting in playing video games using a new technology. The players, some with visual impairment, used gestures instead of keyboards.

31 Aug 2013

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that EYLEA® (aflibercept) Injection has been approved by the European Commission for the treatment of visual impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO).

29 Aug 2013

Study reveals elegant circuit in visual system helps dictate how eyes connect to brain

A study in mice reveals an elegant circuit within the developing visual system that helps dictate how the eyes connect to the brain. The research, funded by the National Institutes of Health, has implications for treating amblyopia, a vision disorder that occurs when the brain ignores one eye in favor of the other.

26 Aug 2013

AMD associated with impaired lysosomal autophagy, study finds

A new study published in the prestigious PLoS One journal changes our understanding of the pathogenesis of age-related macular degeneration. The researchers found that degenerative changes and loss of vision are caused by impaired function of the lysosomal clean-up mechanism, or autophagy, in the fundus of the eye.

22 Aug 2013

International experts on vision and driving coming to metro Detroit

Autonomous cars, driver distraction, and traffic signals for color-blind drivers are just some of the many topics to be discussed at a meeting of international experts on vision and driving, coming to metro Detroit.

16 Aug 2013

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Regeneron Pharmaceuticals, Inc. and Bayer HealthCare today announced that in the Phase 3 VIVID-DME and VISTA-DME trials of EYLEA (aflibercept) Injection for the treatment of diabetic macular edema, EYLEA 2 milligrams (mg) dosed monthly and EYLEA 2 mg dosed every two months (after 5 initial monthly injections) achieved the primary endpoint of a significantly greater improvement in best-corrected visual acuity from baseline compared to laser photocoagulation at 52 weeks.

6 Aug 2013

Research roundup: Eye care disparities; more complications for Medicaid patients after spine surgery; the cost to states opting against Medicaid expansion

After analyzing 2003-2004 data of patients who underwent spinal surgery at two medical institutions, they found that Medicaid beneficiaries were at much higher risk of experiencing any type of complication than patients who are privately insured. "The results of our study further support the growing body of literature that Medicaid patients have higher rates of complications," the authors write. When evaluating patients and considering the likelihood of complications, "Medicaid status should be considered as well," they concluded (Hacquebord et al., 7/15).

20 Jul 2013

Researchers discover new protein that encourages ‘bad’ blood vessel growth

The discovery of a protein that encourages blood vessel growth, and especially 'bad' blood vessels - the kind that characterise diseases as diverse as cancer, age-related macular degeneration and rheumatoid arthritis - has been reported in the journal Nature.

18 Jul 2013

Researchers develop new software that interprets vision of people affected by changes in color vision

Researchers at the University of Alicante have developed new software that will interpret the vision of people affected by alterations in colour vision

19 Jun 2013

pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that the United Kingdom's National Institute for Health and Care Excellence issued draft guidance recommending ILUVIEN for the treatment of pseudophakic patients (those who have undergone prior cataract surgery) with chronic diabetic macular edema considered insufficiently responsive to available therapies.

15 Jun 2013

NICE Appraisal Committee reconfirms clinical effectiveness of ILUVIEN

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that the Appraisal Committee of the United Kingdom's National Institute for Health and Care Excellence has issued a positive Appraisal Consultation Document on ILUVIEN for the treatment of pseudophakic patients with chronic diabetic macular edema considered insufficiently responsive to available therapies.

14 Jun 2013

Research shows visually impaired individuals have greater risk of diminished balance

UC Davis Health System Eye Center research has found that visually impaired individuals and those with uncorrected refractive error - those who could benefit from glasses to achieve normal vision but don't wear glasses - have a significantly greater risk of diminished balance with their eyes closed on a compliant, foam surface than individuals with normal vision.

7 Jun 2013

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that ILUVIEN®, the first sustained release pharmaceutical product for the treatment of chronic diabetic macular edema, is now available in the United Kingdom.

29 Apr 2013

New visual search rehabilitation game for visually impaired children

Visually impaired children could benefit from a revolutionary new computer game being developed by a team of neuroscientists and game designers.

24 Apr 2013

Researchers find innovative approach to treat lazy eye disorder

A research team led by Dr. Robert Hess from McGill University and the Research Institute of the McGill University Health Centre has used the popular puzzle video game Tetris in an innovative approach to treat adult amblyopia, commonly known as "lazy eye".

23 Apr 2013

Despite discovery of sight-saving drugs, AMD still causes severe vision loss in older Americans

Age-related macular degeneration continues to be the leading cause of visual impairment in the United States for people over age 65, according to a study recently published online in Ophthalmology, the journal of the American Academy of Ophthalmology.

4 Apr 2013

Imatinib can relieve and slow down progression of multiple sclerosis

A drug that is currently used for cancer can relieve and slow down the progression of the autoimmune disease multiple sclerosis (MS) in rats, according to a new study published in PLOS ONE.

21 Feb 2013

Visual Impairment News and Research

Latest Visual Impairment News and Research

Increasing eye patching is effective at treating persistent amblyopia in children

Study: People with cataract-related vision loss who undergo cataract surgery live longer

Meta-analysis indicates protective effect of statins in preventing cataracts

CP Family releases video showing children with cerebral palsy playing video games using new technology

European Commission approves EYLEA for treatment of visual impairment due to macular edema following CRVO

Study reveals elegant circuit in visual system helps dictate how eyes connect to brain

AMD associated with impaired lysosomal autophagy, study finds

International experts on vision and driving coming to metro Detroit

Regeneron, Bayer report positive results from Phase 3 VIVID-DME and VISTA-DME trials of EYLEA for DME

Research roundup: Eye care disparities; more complications for Medicaid patients after spine surgery; the cost to states opting against Medicaid expansion

Researchers discover new protein that encourages ‘bad’ blood vessel growth

Researchers develop new software that interprets vision of people affected by changes in color vision

pSivida reports that NICE issues draft guidance for use of ILUVIEN for pseudophakic patients with DME

NICE Appraisal Committee reconfirms clinical effectiveness of ILUVIEN

Research shows visually impaired individuals have greater risk of diminished balance

Alimera announces availability of ILUVIEN in U.K. for chronic DME treatment

New visual search rehabilitation game for visually impaired children

Researchers find innovative approach to treat lazy eye disorder

Despite discovery of sight-saving drugs, AMD still causes severe vision loss in older Americans

Imatinib can relieve and slow down progression of multiple sclerosis

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Visual Impairment News and Research

Latest Visual Impairment News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in